Back to GEN Stock Lookup
Pages: 1 2 »» Last Page

Genon Energy (GEN) – Company Press Releases

Sep 3, 2015 04:15 PM GeneNews' Innovative Diagnostic Laboratory J-V to Provide PHI Testing Services to MD Anderson Cancer Center
Sep 3, 2015 04:15 PM GeneNews' Innovative Diagnostic Laboratory J-V to Provide PHI Testing Services to MD Anderson Cancer Center
Sep 2, 2015 04:14 PM Major Shareholder Announcement
Aug 27, 2015 01:35 AM Data Published in The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses in Heavily Pre-treated Relapsed or Refractory Multiple Myeloma Patients
Aug 24, 2015 07:00 AM Skies Healthcare and Rehabilitation Center Earns Top Distinction in Quality Care
Aug 14, 2015 07:45 AM GeneNews Announces Q2-2015 Financial Results & Provides IDL Progress Update
Aug 14, 2015 07:45 AM GeneNews Announces Q2-2015 Financial Results & Provides IDL Progress Update
Aug 14, 2015 06:37 AM Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology
Aug 12, 2015 01:59 AM Genmab Announces Financial Results for the First Half of 2015
Aug 6, 2015 05:29 PM Genesis HealthCare Reports Second Quarter 2015 Results
Aug 5, 2015 07:30 AM GeneNews' Innovative Diagnostic Laboratory J-V Appoints Dr. Joel V. Brill as Chief Medical Officer
Jul 24, 2015 03:35 PM Genesis HealthCare Files Shelf Registration Statement On Form S-3
Jul 23, 2015 12:46 PM Ten Genesis HealthCare Centers Receive Silver National Quality Award
Jul 22, 2015 08:27 AM Genmab Announces Submission of Supplemental Biologics License Application to FDA for Ofatumumab as Maintenance Therapy for Relapsed CLL
Jul 14, 2015 04:42 PM Genesis HealthCare To Release Second Quarter 2015 Results On August 6, 2015
Jul 10, 2015 11:54 AM Major Shareholder Announcement for Genmab A/S
Jul 9, 2015 01:53 PM Genmab Announces Completion of Rolling Submission of Biologics License Application for Daratumumab in Multiple Myeloma and Achievement of a USD 15 Million Milestone
Jul 7, 2015 07:40 AM Genmab Announces European Regulatory Submission for Ofatumumab as Maintenance Therapy for Relapsed CLL
Jun 23, 2015 01:24 PM Sixteen Genesis HealthCare Centers Receive Bronze National Quality Award
Jun 15, 2015 07:30 AM Genesis HealthCare To Acquire 24 Skilled Nursing Facilities From Revera Inc.
Jun 5, 2015 11:54 AM Genmab Announces Start of Rolling Submission of Biologics License Application for Daratumumab for Double Refractory Multiple Myeloma to the FDA
Jun 2, 2015 01:28 AM Genmab Gains License to Antibody Panel Targeting CD19
Jun 1, 2015 01:01 PM Genesis Rehab Services Partners with Bang-Er to Bring Post-Acute Rehabilitation Services to 11 Hospitals in China
May 28, 2015 10:56 AM Genesis HealthCare to Present at the Jefferies Global Healthcare Conference on June 1, 2015
May 21, 2015 10:14 AM Ofatumumab and Daratumumab Data to Be Presented at 20th Congress of EHA
May 19, 2015 07:30 AM GeneNews Announces Agreement to Increase IDL Ownership Stake
May 19, 2015 01:40 AM Genmab Enters Commercial DuoBody(r) Technology Agreement With BioNTech in Field of Immuno-oncology
May 14, 2015 10:19 AM Genesis HealthCare to Present at the UBS Global Healthcare Conference on May 18, 2015
May 14, 2015 08:45 AM GeneNews Announces Q1-2015 Financial Results
May 14, 2015 08:45 AM GeneNews Announces Q1-2015 Financial Results
May 13, 2015 05:10 PM HuMax-TF-ADC and Daratumumab Data to Be Presented at 2015 ASCO Annual Meeting
May 13, 2015 10:30 AM GeneNews Announces Election of Directors
May 13, 2015 10:30 AM GeneNews Announces Election of Directors
May 12, 2015 11:11 AM Genmab Announces Financial Results for the First Quarter of 2015
May 7, 2015 07:00 PM PowerBack Rehabilitation Set to Open in Lafayette
May 7, 2015 04:27 PM Genesis HealthCare Reports First Quarter 2015 Results
May 6, 2015 07:14 AM First Quarter 2015 Net Sales Figures for Arzerra(r) (Ofatumumab)
Apr 30, 2015 04:23 PM Genesis HealthCare to Present at Bank of America Merrill Lynch's HealthCare Conference on May 13, 2015
Apr 28, 2015 07:15 AM GeneNews to Present at the 2015 Bloom Burton & Co. Healthcare Investor Conference
Apr 28, 2015 07:15 AM GeneNews to Present at the 2015 Bloom Burton & Co. Healthcare Investor Conference
Apr 27, 2015 10:26 AM Genmab Announces Phase III Study of Arzerra(r) Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL
Apr 17, 2015 11:42 AM Genesis HealthCare To Release First Quarter 2015 Results On May 7, 2015
Apr 16, 2015 09:46 AM Genmab Achieves USD 10 Million Milestone in Daratumumab Collaboration with Janssen
Mar 31, 2015 06:14 PM GeneNews Announces Q4 and Full Year 2014 Financial Results
Mar 31, 2015 06:14 PM GeneNews Announces Q4 and Full Year 2014 Financial Results
Mar 26, 2015 02:09 PM Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to two Board Members and Grant of Warrants to Employees in Genmab
Mar 18, 2015 10:14 AM Genmab Acquires Antibody Assets from iDD Biotech
Mar 16, 2015 06:36 AM Genmab Retains Partial Rights for HuMax-TAC-ADC - Will Not Exercise Co-development Right
Mar 11, 2015 01:16 PM Capital Increase in Genmab as a Result of Employee Warrant Exercise and Projection of Improved Cash Position at the End of 2015
Mar 9, 2015 10:44 AM Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 11, 2015
Pages: 1 2 »» Last Page

Back to GEN Stock Lookup